List of Tables
Table 1. Global Market Multiple Sclerosis Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Multiple Sclerosis Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Multiple Sclerosis Therapeutics Market Size Share by Region (2018-2023)
Table 4. Global Multiple Sclerosis Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Multiple Sclerosis Therapeutics Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Multiple Sclerosis Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Multiple Sclerosis Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Multiple Sclerosis Therapeutics Revenue Market Share by Type (2018-2023)
Table 9. Global Multiple Sclerosis Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Multiple Sclerosis Therapeutics Revenue Market Share by Type (2024-2029)
Table 11. North America Multiple Sclerosis Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Multiple Sclerosis Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Multiple Sclerosis Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Multiple Sclerosis Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Multiple Sclerosis Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Multiple Sclerosis Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Multiple Sclerosis Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Multiple Sclerosis Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Multiple Sclerosis Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Multiple Sclerosis Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Multiple Sclerosis Therapeutics Market Size (US$ Million) by Distribution Channel: 2018 VS 2022 VS 2029
Table 22. Global Multiple Sclerosis Therapeutics Market Size by Distribution Channel (2018-2023) & (US$ Million)
Table 23. Global Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2018-2023)
Table 24. Global Multiple Sclerosis Therapeutics Forecasted Market Size by Distribution Channel (2024-2029) & (US$ Million)
Table 25. Global Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2024-2029)
Table 26. North America Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2018-2023) & (US$ Million)
Table 27. North America Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2024-2029) & (US$ Million)
Table 28. Europe Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2018-2023) & (US$ Million)
Table 29. Europe Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2024-2029) & (US$ Million)
Table 32. Latin America Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2018-2023) & (US$ Million)
Table 33. Latin America Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Multiple Sclerosis Therapeutics Revenue by Distribution Channel (2024-2029) & (US$ Million)
Table 36. Global Multiple Sclerosis Therapeutics Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Multiple Sclerosis Therapeutics Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Multiple Sclerosis Therapeutics as of 2022)
Table 39. Date of Key Players Enter into Multiple Sclerosis Therapeutics Market
Table 40. Global Multiple Sclerosis Therapeutics Key Players Headquarters and Area Served
Table 41. Multiple Sclerosis Therapeutics Product Solution and Service
Table 42. Global Multiple Sclerosis Therapeutics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Novartis Basic Information List
Table 45. Novartis Description and Business Overview
Table 46. Novartis Multiple Sclerosis Therapeutics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Multiple Sclerosis Therapeutics Business of Novartis (2018-2023)
Table 48. Novartis Recent Developments
Table 49. Teva Pharmaceuticals Basic Information List
Table 50. Teva Pharmaceuticals Description and Business Overview
Table 51. Teva Pharmaceuticals Multiple Sclerosis Therapeutics Products, Services and Solutions
Table 52. Revenue (US$ Million) in Multiple Sclerosis Therapeutics Business of Teva Pharmaceuticals (2018-2023)
Table 53. Teva Pharmaceuticals Recent Developments
Table 54. Sanofi Genzyme Basic Information List
Table 55. Sanofi Genzyme Description and Business Overview
Table 56. Sanofi Genzyme Multiple Sclerosis Therapeutics Products, Services and Solutions
Table 57. Revenue (US$ Million) in Multiple Sclerosis Therapeutics Business of Sanofi Genzyme (2018-2023)
Table 58. Sanofi Genzyme Recent Developments
Table 59. Bayer Basic Information List
Table 60. Bayer Description and Business Overview
Table 61. Bayer Multiple Sclerosis Therapeutics Products, Services and Solutions
Table 62. Revenue (US$ Million) in Multiple Sclerosis Therapeutics Business of Bayer (2018-2023)
Table 63. Bayer Recent Developments
Table 64. Pfizer Basic Information List
Table 65. Pfizer Description and Business Overview
Table 66. Pfizer Multiple Sclerosis Therapeutics Products, Services and Solutions
Table 67. Revenue (US$ Million) in Multiple Sclerosis Therapeutics Business of Pfizer (2018-2023)
Table 68. Pfizer Recent Developments
Table 69. Biogen Idec Basic Information List
Table 70. Biogen Idec Description and Business Overview
Table 71. Biogen Idec Multiple Sclerosis Therapeutics Products, Services and Solutions
Table 72. Revenue (US$ Million) in Multiple Sclerosis Therapeutics Business of Biogen Idec (2018-2023)
Table 73. Biogen Idec Recent Developments
Table 74. Merck Basic Information List
Table 75. Merck Description and Business Overview
Table 76. Merck Multiple Sclerosis Therapeutics Products, Services and Solutions
Table 77. Revenue (US$ Million) in Multiple Sclerosis Therapeutics Business of Merck (2018-2023)
Table 78. Merck Recent Developments
Table 79. AbbVie Basic Information List
Table 80. AbbVie Description and Business Overview
Table 81. AbbVie Multiple Sclerosis Therapeutics Products, Services and Solutions
Table 82. Revenue (US$ Million) in Multiple Sclerosis Therapeutics Business of AbbVie (2018-2023)
Table 83. AbbVie Recent Developments
Table 84. North America Multiple Sclerosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 85. North America Multiple Sclerosis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 86. Europe Multiple Sclerosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 87. Europe Multiple Sclerosis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 88. Asia-Pacific Multiple Sclerosis Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 89. Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 90. Asia-Pacific Multiple Sclerosis Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Multiple Sclerosis Therapeutics Market Share by Region (2018-2023)
Table 92. Asia-Pacific Multiple Sclerosis Therapeutics Market Share by Region (2024-2029)
Table 93. Latin America Multiple Sclerosis Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 94. Latin America Multiple Sclerosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 95. Latin America Multiple Sclerosis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 96. Middle East & Africa Multiple Sclerosis Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 97. Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 98. Middle East & Africa Multiple Sclerosis Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 99. Multiple Sclerosis Therapeutics Market Trends
Table 100. Multiple Sclerosis Therapeutics Market Drivers
Table 101. Multiple Sclerosis Therapeutics Market Challenges
Table 102. Multiple Sclerosis Therapeutics Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Sclerosis Therapeutics Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Multiple Sclerosis Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Multiple Sclerosis Therapeutics Market Share by Regions: 2022 VS 2029
Figure 4. Global Multiple Sclerosis Therapeutics Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Multiple Sclerosis Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Multiple Sclerosis Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Multiple Sclerosis Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Multiple Sclerosis Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Multiple Sclerosis Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Beta Interferon
Figure 11. Global Beta Interferon Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Corticosteroids
Figure 13. Global Corticosteroids Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Monoclonal Antibodies
Figure 15. Global Monoclonal Antibodies Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Product Picture of Antineoplastic Agents
Figure 17. Global Antineoplastic Agents Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Product Picture of Others
Figure 19. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 20. Global Multiple Sclerosis Therapeutics Market Size Share by Type: 2022 & 2029
Figure 21. North America Multiple Sclerosis Therapeutics Revenue Market Share by Type (2018-2029)
Figure 22. Europe Multiple Sclerosis Therapeutics Revenue Market Share by Type (2018-2029)
Figure 23. Asia-Pacific Multiple Sclerosis Therapeutics Revenue Market Share by Type (2018-2029)
Figure 24. Latin America Multiple Sclerosis Therapeutics Revenue Market Share by Type (2018-2029)
Figure 25. Middle East and Africa Multiple Sclerosis Therapeutics Revenue Market Share by Type (2018-2029)
Figure 26. Hospital Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 27. Retail Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 28. e-Commerce Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 29. Global Multiple Sclerosis Therapeutics Market Size Share by Distribution Channel: 2022 & 2029
Figure 30. North America Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2018-2029)
Figure 31. Europe Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2018-2029)
Figure 32. Asia-Pacific Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2018-2029)
Figure 33. Latin America Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2018-2029)
Figure 34. Middle East and Africa Multiple Sclerosis Therapeutics Revenue Market Share by Distribution Channel (2018-2029)
Figure 35. Multiple Sclerosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 36. Global Top 5 and Top 10 Players Multiple Sclerosis Therapeutics Market Share in 2022
Figure 37. North America Multiple Sclerosis Therapeutics Market Share by Country (2018-2029)
Figure 38. U.S. Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 39. Canada Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 40. Germany Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 41. France Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 42. U.K. Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 43. Italy Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 44. Russia Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 45. Nordic Countries Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 46. Asia-Pacific Multiple Sclerosis Therapeutics Market Share by Region (2018-2029)
Figure 47. China Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 48. Japan Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 49. South Korea Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 50. Southeast Asia Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 51. India Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 52. Australia Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 53. Latin America Multiple Sclerosis Therapeutics Market Share by Country (2018-2029)
Figure 54. Mexico Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 55. Brazil Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 56. Middle East & Africa Multiple Sclerosis Therapeutics Market Share by Country (2018-2029)
Figure 57. Turkey Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 58. Saudi Arabia Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 59. UAE Multiple Sclerosis Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 60. Bottom-up and Top-down Approaches for This Report